Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126959611 | 12695961 | 1 | I | 201606 | 20160824 | 20160829 | 20160829 | EXP | US-SUNOVION-2016SUN002100 | SUNOVION | 47.00 | YR | F | Y | 0.00000 | 20160829 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126959611 | 12695961 | 1 | PS | LATUDA | LURASIDONE HYDROCHLORIDE | 1 | Oral | 40 MG, UNK | Y | UNKNOWN | 200603 | 40 | MG | TABLET | |||||
126959611 | 12695961 | 2 | SS | VISTARIL | HYDROXYZINE PAMOATE | 1 | UNK | Y | 0 | ||||||||||
126959611 | 12695961 | 3 | C | SEROQUEL | QUETIAPINE FUMARATE | 1 | UNK | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126959611 | 12695961 | 1 | Bipolar disorder |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126959611 | 12695961 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126959611 | 12695961 | Blister | |
126959611 | 12695961 | Blood glucose increased | |
126959611 | 12695961 | Oral mucosal blistering |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |